BioAtla
BCAB
BCAB
81 hedge funds and large institutions have $518M invested in BioAtla in 2021 Q4 according to their latest regulatory filings, with 15 funds opening new positions, 34 increasing their positions, 16 reducing their positions, and 19 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
7% less funds holding
Funds holding: 87 → 81 (-6)
21% less first-time investments, than exits
New positions opened: 15 | Existing positions closed: 19
31% less capital invested
Capital invested by funds: $746M → $518M (-$228M)
Holders
81
Holding in Top 10
2
Calls
$2.09M
Puts
$160K
Top Buyers
| 1 | +$18.5M | |
| 2 | +$8.37M | |
| 3 | +$6.19M | |
| 4 |
TCM
Tang Capital Management
San Diego,
California
|
+$5.85M |
| 5 |
WP
Woodline Partners
San Francisco,
California
|
+$5.8M |
Top Sellers
| 1 | -$17.3M | |
| 2 | -$10.4M | |
| 3 | -$5.78M | |
| 4 |
FCM
Farallon Capital Management
San Francisco,
California
|
-$5.3M |
| 5 |
MIM
Monashee Investment Management
Boston,
Massachusetts
|
-$5.26M |